Study on different factors affecting the bionic enzymatic hydrolysis of icariin

Yaoxue Xuebao

Volumn 48, Issue 11, 2013, Pages 1716-1721

  Gao, Xia ^a,b   Chen, Yan ^b   Wang, Ying ^b   Sun, Wen Jie ^a,b   Jia, Xiao Bin ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

Author keywords

glucosidase; Baohuoside I; Bionic enzymolysis; Icariin; Surfactant

Indexed keywords

BAOHUOSIDE I; BETA GLUCOSIDASE; BUFFER; CELLULASE; ICARIIN; NICOTINIC ACID; PANCREATIN; RHAMNOLIPID; UNCLASSIFIED DRUG; FLAVONOID; HYDROLASE; SURFACTANT;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; HYDROLYSIS; IN VIVO STUDY; REACTION TIME; STOMACH JUICE; ANIMAL; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; ISOLATION AND PURIFICATION; METABOLISM; SNAIL;

ANIMALS; BETA-GLUCOSIDASE; CELLULASE; FLAVONOIDS; HYDROLASES; HYDROLYSIS; PANCREATIN; SNAILS; SURFACE-ACTIVE AGENTS;

EID: 84890962834     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zhang YD, Cai YN, Zhang Q, et al. Inhibitory effect of icariin on acetyl-cholinesterase [J]. Acta Pharm Sin, 2012, 47: 1141-1146.
2. Qiu F, Chen YJ, Kano YH, et al. Metabolism of orally administered icariin in rats [J]. Acta Pharm Sin, 1999, 34: 222-226.
3. Liu XX, Zhang YZ, Li ZH, et al. Effect of baohuoside-I on Wnt/β-catenin signaling pathway of human esophagealcarcinoma cell Eca-109 [J]. Chin Tradit Herb Drugs, 2011, 42: 124-126.
4. Kim SH, Ahn KS, Jeong SJ, et al. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells [J]. Eur J Pharmacol, 2011, 654: 10-16.
5. Huang J, Yuan L, Wang X, et al. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro [J]. Life Sci, 2007, 81: 832-840. (Pubitemid 47337100)
6. Yang QX, Liu YQ, Wang L, et al. Screening of bioactive components in epimedium for osteoporosis treatment by model population analysis [J]. Acta Pharm Sin, 2012, 47: 1205-1209.
7. Han S, Xie YY, Wang YM. Comparative study on chemical quality of main species of epimedium [J]. Acta Pharm Sin, 2012, 47: 502-507.
8. Wang Y, Harvey CB, Hollox EJ, et al. The genetically programmed down-regulation of lactase in children [J]. Gastroenterology, 1998, 114: 1230-1236. (Pubitemid 28243909)
9. Bacsi K, Kosa JP, Balla B, et al. The decreased activity of lactase phlorizin hydrolase and bone mineral density in postmenopausal women [J]. J Bone Miner Res, 2007, 22: S186.
10. Zhang ZH, Chen LL, Jia XB, et al. Preparation technology of baohuoside I by enzymolysis of icariin with β-glucosidase [J]. China Pharm, 2011, 22: 4059-4061.
11. Jia DS, Jia XB, Xue J, et al. Study on preparation of icaritin by enzymolysis of icariin with snail hydrolase [J]. China J Chin Mater Med, 2010, 35: 857-860.
12. Park JW, Takahata Y, Kajiuehi T, et al. Effects of nonionic surfactant on enzymatic hydrolysis of used news paper [J]. Biotech Bioeng, 1992, 39: 117-120.
13. Mo D, Yuan XZ, Zeng GM, et al. Effect of Tween 80 and rhamnolipid on enzymatic hydrolysis of straw [J]. Environ Sci, 2008, 29: 1998-2004.
14. Collnot EM, Baldes C, Schaefer UF, et al. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access [J]. Mol Pharm, 2010, 7: 642-651.
15. Jin X, Zhang ZH, Chen LL, et al. Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on baohuoside I across membrane transport of Caco-2 monolayer model [J]. Chin Tradit Herb Drugs, 2011, 42: 2474-2478.
16. Cui SM, Ye ZZ, Zhang J, et al. Progress in pharmaceutical excipients with function of inhibition of P-glycoprotein mediated efflux [J]. Chin J Pharm, 2012, 43: 785-789.
17. Zhou XX, Song SS, Wang DK. Advantages of vitamin E TPGS and its P-glycoprotein inhibiting mechanism [J]. Chin J New Drugs, 2012, 21: 2758-2762.